Ethics approval and consent to participate.DeclarationsĪll manuscripts must contain the following sections under the heading 'Declarations': If abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviations should be provided. This should state clearly the main conclusions and include an explanation of their relevance or importance to the field. This should contain the body of the article, and may also be broken into subsections with short, informative headings. The Background section should explain the background to the article, its aims, a summary of a search of the existing literature and the issue under discussion.
Each key point should contain no more than 12 words and be aimed at a general audience. Three to five keywords representing the main content of the article.Īll submissions require three to five key points that highlight the main message(s) of the article. Please minimize the use of abbreviations and do not cite references in the abstract. The abstract should not exceed 250 words and should be structured with a background, main body of the abstract and short conclusion. If you would like the names of the individual members of the Group to be searchable through their individual PubMed records, please include this information in the “Acknowledgements” section in accordance with the instructions below.
#ENDNOTE FORMAT NAME MOLECULAR THERAPY FULL#
list the full names, institutional addresses and email addresses for all authors:.or for non-clinical or non-research studies: a description of what the article reports."A versus B in the treatment of C: a randomized controlled trial", "X is a risk factor for Y: a case control study", "What is the impact of factor X on subject Y: A systematic review".present a title that includes, if appropriate, the study design e.g.:.
0 kommentar(er)
